神经内科疾病临床诊治 2018年版_第1页
神经内科疾病临床诊治 2018年版_第2页
神经内科疾病临床诊治 2018年版_第3页
神经内科疾病临床诊治 2018年版_第4页
神经内科疾病临床诊治 2018年版_第5页
已阅读5页,还剩210页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

神经内科疾病临床诊治主编

帆前

言,,,,,,》。,,,,,,,,,,201811

目录CONTENTS 126102237414346576478 81C 90C(T)931(MRI)96SPECT

101 107 112120

135142143151241541561601621641651671701731761781822第一章

脑血管病的病因及危险因素第一节

脑血管病的病因,,,,(),,,,,1.,,,,,,

,,,,,,,2.,,,,,,,,,,,,,,,,,,,,B,,(inswanger),B,1,()-,(),()(),,,血液动力学因素,,,,第二节

脑血管病的危险因素,,,1.,,,(≥,90mmHg),10mmHg,49%,5mmHg,215μmolL15μmolL,≥16μmolL546%(),51.

,,,4,58%,(),,2.,,,,,55 853%5%,50%55 85,0591.%,08923.%5,,68%7,9.5,7

, P45.4(0.05)。 P420%

,40% 6820.%,

10% 6823.,,

2,,,L4.,,L(DL),5.,,,B12,B12(),

5//405926%,≥6035%405921%,≥6037%6.20%,31%15%,,57.,,,2Jdi di11di45Jdi di11di,2“rnk”(

“rnk”1114g),4,50ml(

,30g),640ml,200ml()5“rnk”,a8.aMil,20%,10,2.Bl

,(MI)BlWaker40752864323,231.9,/2.39 97

B9

B39 97

B9

B3BMI2728.

1.5,MI2931.1.0,MI322.718,BMI69.,,6,,45,5%14%3.%,10.,35,,411.

,,,,,,5第二章

脑血管病的解剖学基础第一节

(2-1)。,,(),1.,1(),()1,,,,图2-1脑解剖示意图62(),23B()(roca):3B,,,4(),,4,2.,12(),,12(),,3(),3,,,,,,3.,,,,1(),,,1,,23(),23(),,,4.,,,,,,5.,,,,,,(),,()1.,,,7,,,,,2.,,,,,,,,()(),,,,,,,1.,,,,,,,1()():1HE,40%,,,,,,,10%,,,,(),(),850%,,,,2()():,2,,(),,,,,,,,2.,,,3.,,,,,(),,,()。,,,,,(),,,,,,,,,,,,,,,,,,,,,,(),9,,,,,,,,,,,,,,,,,第二节

脑神经,12,,,1.2.3.4.,,5.6.7.,,,,,,,,,,,,24,10(),,,,,,,,,脑神经损伤的解剖学基础(),,20,,

,,,,,,,,,,,,,,,1.1(),123(),23,CT

()():,,CTMRI4(),,4C,,XT

C2.12(),,12,,(),,(),52.3cm,,5112,11.cm,,,2,,,,,(),,,,,,,,(),,,,,,,,,,,1,,610,,,,,1/3,30°,,,,(),,,,,,,,,(),,,,,3,,,,12(),,,,,,123,1.,,,,1(),,,123,,,2,,2(),,,,,,3(),3,,,,,2.,,,1,,,1(),,,,2(),,,,2,33(),33,,

,4(),23,,,4(),,,,3.,,,,13,,2/3,12(),12,,,,,,(),3(),3,2/3,,,2/3,2/3,,,4(),,,,4,,,,5(),,54,,,,,(),,,,,,,,(),,,,,,,2/3,,,,,,,,,,,,,141.1(),,1,,,2/3,,,2(),,,2,,,,,,,3()32.,,,,,12()3,12()34,3()34,,34(),45(),5,,,,,,,,,,,,,,,,,2/3()(),,151.,,,,,,2.(),,,,,,,,11,,,,,,,()2()()、2(),,,,,,,1/3,,,,,1/3,,,,,,,,,,1.,1/3,2.34,,,3.,,,,,,,,,,4.12,,16,,,,,,,,,,,1/3,(,),(),,,,,,,(),,,,,,,,,,,,,,,,,,,,,1.12(),,12,,,,,(),,,,,3(),,34(),,417,5(),52.12()12,,,,,,,,,,,,,,,,,(),,,,3.()1(),46,1,“”2(),,,23(),,3,4(),,,4,,,,(),,,,,,,,,,,,,18,,,1/3,1/3,,,,,,,1/31/3

,,,(),,,,,,,,,,,,眼的神经解剖学基础以及临床联系()1.1()123()23()4(),42.12()():12()():3.,,610,,,,,,,,,,,,6,19,,,1,,,,,,()1.,1,,1,,,,,,(),(),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Gurm,,,,,2,,,,,,2(),2,,,,,,,,,,,,,,,-,20,,(),,,,,,,,,,,,,2,,,,3(),3,,,,,,,,,,,,,,1,(

2),,14,(),,4(),,,,,,,,135,()5(),,,,1/31/4li,,li,,,,,,,,,,,

Wils6(),6,,,,,21,,,,,,7(),,7,,,,,,,,,(),,,,,,,,(),,,,,,,,5,30°40°,5,(°10°)第三节

脑血管2%,20%,,1.,,2.,3.,4.,5.()(),,,226.7.8.()9.-,,,--,10.11.,-,,2/3,1/3-,-,,,(),,,,,,,,,,,, CC3CC332 CC3CC332(5):,(4):,(C

):,C(2),(1):C

C

C

1.,,,,,,,,,,,,,2-323图2-2颈内动脉造影图图2-3大脑半球内侧面、脑干和小脑动脉的分支与分布(2-4):1(),12(),,,2,3(),,,3,,,,1/4,244(),,4,,2/3,,,,,图2-4大脑半球外侧面和小脑动脉的分支与分布,,,1/4,,,,,,()。()。,,,2.,,,,,,,,,60%,,40%58,,,25,,,,(2-5)。,,,,,,,,,,,,,1(),,,1,,

Broca()2(),,,2323/4(46)。,,33, 24(),33, 24,3/4(4,

1

,340)。,图2-5大脑中动脉的皮质支与中央支424(),424,,3/4(1

07)。,26,,4,3,,3,54(),,54,,(0)6(),,67(),,72

2(122

282

249 2

24()82

249 2

24,(12412)。(),,,,,(412,1237)。1(0),13,,,,3(9),,,,3/4,,,,,,,,,,()()3.()-,61,,,,,,,,,1.1(),12(),,,2,1/3()273(),3,,,,4(),,4,,,2.,(2-6)。1()1/3,1,2(),,,,2,80%3()10,,34(),,4()、图2-6脑底面的动脉分支5(),,,528,,,-,,,,,,,,,(2-7):,,,,,23,,,,,,,,,,,,,,,1/3,()。,,,,,图2-7大脑后动脉的分支与分布()lilili-Willilili,

WilsWils,,,2935048%,(27%);14%,7%(2-8)。,,,,,图2-8大脑动脉环左侧发育不良(左侧大脑后动脉发自颈内动脉代替部分后交通动脉)(),,,,,,,,(2-9)。1.1()34,,1,2()23,,2,3(),,3,,,(),15,30图2-9大脑动脉环中央支的分群2.,,,,,,,,,3.,,,,,1cm,13,,1cm,14,,,,,,,

S,,(2-10,2-11)。4.16,34,,31图2-10丘脑和低丘脑的动脉供应图2-11基底核和丘脑的动脉供应,,,,,,,,,,,,32,(),,(2-12,2-13)。图2-12大脑半球背外侧面的静脉图2-13大脑半球内侧面的静脉1.()1015,79,,,,67,,,,,,,,33,,,,,,,,1cm,,,5,11.cm,,52.13,,,,,,,3.,,,(),(2-14),,图2-14大脑大静脉及其属支341.,,,1(),,,12()2cm,2,,,,,,,3(),,3

,,2.,,,,,,(2-15)。图2-15基底静脉的形成与属支351(),(1)2(),2,,3.,,,,脑各部的血液供应1.,(2-16)。,,3/42.,,(2-17)。3.,图2-16大脑半球背外侧面的动脉分布区36图2-17大脑半球内侧面的动脉分布区第四节

脑脊液140180ml,150ml,(3040ml

2530ml

5565ml

1015ml2030ml)。,7 7582420.81.6kPa(.513.mmHg),3.7 758242,,,,,600700ml,4580%85%,,,,,()。,,,,,,,(,,

TrypanBlue,(,),,37,,-,6nm,,,,,,,,,,,,,,,,,,,,,,,,(2-18)。41,1.7kPa41(1mmHg),,,,,,6μm(2-19)。,,,,,,,,,,,,38图2-18脑脊液循环图2-19蛛网膜粒与上矢状窦的关系39脑脊液的化学成分和功能00/ /

4/5,,00/ /

4/5,,-,液中蛋白,200

L(65%),60%70%,2.4.mmolL(575mg100ml),,,,,,,,,,,,,,,,

Ca2+K+Mg2+,,40第三章

脑血液循环的病理生理学,,,,,68,,(1020)345,,30,68,48/3208822 2 /C///3208822 2 /C//241100L,1.8ml,1.0ml,1.5ml,1.3ml,0.7ml0.ml,0.00.3ml,2%3%,15%20%(),100g(MRO

)3mlmin,45ml2465L,25%,48gh,24115g2.mmolL,第一节

生理条件下脑血流量的调节 /g0 /g565

/g10 /g0 /g565

/gmin)。,25,0.40.2ml(·min)。50,0.ml(·min)。20%,40%41 /g60.5ml(·min), /g6,,,,,脑血流量的调节,,,-(),,,,,,i(,Baylss(MABP)i(70

Adams-Stokes)、60mmHg,60%,,30%,,(),,,,,,()31.-,[5kPa(7.5mmHg)]3,,,,,2.-,,,42//g770g

L,,0.9ml(·min//g7,,3.,1()1, P22()(aO

): P22

,85%100%13%15%,35%,,,,,,,51P2 /g911%15%2.kPa(51P2 /g9,pH,(aCO

):()5%7%0.3ml(·min)。,,,pHpH,,,3,pH,3,pHpH,

HCO

H+,,第二节

脑血管病变时脑血流量的调节(=-),,,43,40%(50mmHg),,,,,,,,,,,,,1.,30%40%,,,,2.,23,,,,223.,,22,PaCO

,

PaCO

,,,,,,,,()。,,,()。124.,,,5.,,,6.5%,,,,,,,44,,60%,,,,,,,,45第四章

神经系统损害的定位诊断,,,第一节

脑神经(),,,,,,,()(),,,,,,,,,()(4-1):(4-1a)。()(4-1b)。,,(4-1c),,(4-1d),(4-1e)。,,,,,(4-1fh)。46,,,(4-1i)。图4-1视通路损害的定位症状()、()、()(),,(4-1),表4-1眼球运动神经支配与功能47()1.,,,,,,,,,it

l(4-2)。Ednger-Wespha

(E-Wit

l(),图4-2眼球运动的神经支配2.,,,,,,()3.,,,(),,,,,()1.1(),,1,,(4-3)。48图4-3动眼神经麻痹图4-4展神经麻痹2(),,23(),(4-4)。32.1()1,,,(

laeF

i-

Milrd-Gubl(

laeF

i,(ovlesyndrome)。2c(),2c,,,,(Wernike)3.(4-5)束综合征,P,P(PRF),,P

,,,,,P

(PRF),,

,,ol(neandha)ol

可出现一,

,

,

49图4-5核间性眼肌麻痹4.,,,1()1(),,,,,,,,,,(),,,,(4-6)。50图4-6两眼同向凝视的神经支配 P

i2()(ar P

i2 o

a o

aii,

(culrcrss),()、5.,,,,,,,,,,,,56.(,)5(,)1. 553.,2., 551 ( (1 ( (

)

(

)

,

6mm)

,

2(),2(

),()、((),(4-74-8)。,,51图4-7眼交感神经通路图4-8瞳孔光反射通路3(),3E-W,()、,,(),,4P

ia(tl4P

ia(tl,,(eri

),,,E-W,,-

Argyl-Robersonpupi),,,(

il,

Ad(

il()(),1,

,:(4-9)1(),,2(),,,3(),52,,,2,,,(2),(3),,,3,,,图4-9三叉神经解剖(),,

,,

,

()()53,,,2/3,,,,,(),(),,2/3,,,()Bl(1.,Bl(,(el)

(4-10):,2/3,2/3,,

Huntsyn-),图4-10面神经损害的定位2.,,,,,54()()C

t1.,,(C

t),,,,,2.,,,,(4-11)。图4-11前庭神经的纤维连路()1.1 i t

i 1 i t

i ((

)。

,

)、

)、

55 h

rn

e

tod

f2()

h

rn

e

tod

f2,,

,,

( ,

,

病变引起,,,

,,(

)、

)和动脉硬化所致的内

(

),v

t in

tii2.(erigo)、v

t in

tiiton),,,,-,,()、()()1.,,1/3,1/3,,,,,,2.,

,

,

,

,

(),,,,,,,()()56()()16,,,,,,,,,,,,,,,,第二节

感觉系统()()。()2

2

1,

()()感觉的神经传导通路,(),,,,(,,),,,,,,,,,,57(),(4-12)。,,,(),()。()1/3,,(),(),,,,(),,()。,,(4-13)。,,127,,12723,,(3

),,(4-14)。(5

)图4-12感觉通路58图4-13脊髓传导束的纤维排列(示意图)图4-14躯体各部位在大脑半球感觉代表区的分布()(),,,(),()(),(),,()。(),(4-13),4(),4()(),(t

i1.

hypereshesa)(t

i(2.

hyperpathi),(,,,,,59“”, t

ip3.(areshesa), t

ippi4.(an),pi,,(l

l

ir

i

i i),l

l

ir

i

i i(adatngpan):,,,siiricli,siiricli

,,

(e-ferredpan):,,,,(ausaga):,, li ip li ip

C,,

C,(hantomlmbpan):(ighte-ningpan):,,,,,5.(),(),(),,(),(),()(),,1.,,,,(4-15)。60图4-15末梢型感觉障碍2.,,,45,781(4-16)。(),3.,(4-17),,()4.1(),1

(),,(4-18a)。,,2(),2(4-18b)。61图4-16神经干型感觉障碍bca.神经根、干、丛;.上干型感觉分布;bcb图4-17第5~6颈髓神经根损害图4-18脊髓型感觉障碍a.后角型;.前连合型b3()3,(),,62,,,,,()。,B,(rown-Sfequard)B(4-19)。,(4-20),图4-19Brown-Sequard综合征图4-20脊髓横贯性损伤5.,,,,,,,,(4-21)。,,6.,()(4-22),,7.1/3,,(4-22);,,()。63图4-21延髓外侧综合征图4-22右侧内囊或丘脑损伤8.,(4-14),,,,,,,第三节

运动系统-----()、()1.(),,,64,,,(),,,,5(14)、(51)、(14)、(54)(5),,,(4-23),()图4-23肌肉节段型神经支配、周围神经及神经根676 567Ⅰ、Ⅱ、Ⅲ三个节段发出5、、

三个神经根。5、

神经根组成3号神经支配肌肉2,、、

676 5679 1神经支配肌肉1。8、

为前角细胞群,0为脊髓9 12.,,,14(),,3145f

i

aifif

i

aifi,,(ascculton),,(ibrlaton)。2(),2,,,3(),36544(),,,())1.

(

)

,

criilrt rilrrcriilrt rilrrtcotbatac)。110,

B6127(4B6127

,(3

)(5

)z,

Bet

(120μm)4zz2

Bet

3%,,(z2)40%4,0%,(6)(4-24)。4-24大脑皮质功能代表区;a.外侧面

b.内侧面;J(4),J,4,,,(4-25)。,4(ackson),

4,66,,图4-25躯体各部位在大脑皮质的运动代表区

图4-26内囊与放射冠,()2/3()(4-26)。3/5,,,, l ip85%,(yramida l ip523,523,,,(4-27)。(),0%,0%,0%,,,5

,,,(), feγarlγ(-relxloop) feγarlγ,(nnu-lospiareceptor),,α,,,67(4-28)。(),,,,,()γ,,,,α,,,,α,,,γ,7,,,,,图4-27锥体束的传导通路图4-28牵张反射弧与肌张力增高b.a.牵张反射弧;

7b.682.(),,cafds,“”(lsp-knie),cafds,(omi),,(),,,,,,,,,,,,,,,,,,,,,,,,,,4-2表4-2中枢性与周围性瘫痪的鉴别 () () ,() ,(),,(

,,)3.,691(),,1,()。,,(4-29a)。,,,

2(),2(4-29b)。,,,“”(),,,,图4-29椎体束损害定位模式图解3la ei(),3la ei,,(4-29C)。,

,,

Milrd-Gublr,,

Fovle,,704(),4,,,,(4-29d)。,,,,,,,,B,,,(rown-SSquard)B(4-19)。1.,,,sll(ubthaamicnuceus,Luys)、sll,(4)(6)。cn

titipe

ti(orpussratum)cn

titipe

tilosratum)。,pli,,,,pli,,,,,,(al)。4-30图4-30纹状体结构的隶属关系,,,1()(),

1,718(4)(6)8(4ss),5-((γ-

GABA),

P2()(),2ae

i

aif

ie

i

aiae

i

aif

ie

i

ai,--(),(4)(6)(4-31)。图4-31纹状体-苍白球系统与锥体外系统的练习,,,,,,,,,,72lKinnerWison,l,,4s()8s,,(46),,,,();()();,,2.,,,,,,,1riliics

tcliii()1riliics

tcliii,,,(ead-piper-gdty)。,,(rgdty),-(pasi-tiy),,t2s

i

rpl3c2s

i

rpl3ci,,48,“(ilroling)”,()(horecmovement):,,,4 ai()(thetoss):4 ai,,“”,(l

mobiespasm)。(l)5t

id

tf()(ors)5t

id

tf,,,6hli()(emibalsmus):6hli737 tc,,,7 tc()(i):,,,dt

ifilia(a)dt

ifilia(ardvedyskinesa),(aca/oro-fac

ldyskinesa),,,i(le

Mege

GilsdelaTouretei(le

(4-3)。表4-3锥体系和锥体外系综合征的临床鉴别要点

() ()();, (), ,,S,,S,,,,(7)-(Npr),1.(),,,,()、()(),,,,,74fa,,fa,,,(rlobe)。,V,V,“

”,,(4-32,4-33)。图4-32小脑半球上面观图4-33小脑半球下面观,,Pe(urkinj,)Pe,

,ci(i(lmbingfbres),ci(i

mossyfbres),,bsla ll,bsla ll,(asketcel)(teltecel),

,,,,(),(4-34)。75图4-34小脑传入纤维与传出纤维Ca,Ca()()(lrke,),,,,,,,,(),,--,,(),,(),,--,,[F

l(ore)],,,F

l76--,,46F

l,F

l,,,3()(ore)a la l,,,,(rchierebelum),,pllpll,(alum),,nl(),nl(lum),,,,2.,,(),,,,,,,,,,,,,,,ve(on-Hippl-Lindau)ve1()1aainito(txainain):aainito小脑病变时,,Rr

(g);

Rr,

,,,,

,,,“”。d ra(ysmeti):d ra,,t(remor):t77,si

i(kewdevaton),si

i,,,

,2()(),,2,,,,,,,,,,3(),3,,,,--,4(),,4,第四节

反射,()、()()。,(),,(),,,,()、()、,,,,,4-478表4-4浅反射定位

7891 1112

12()12()

,

1

45,(1)(),1

,,,4-5表4-5深反射定位

3

56

叩击鹰嘴上方

56

68

58

24/ 1279(),,,,,,,,,,,,,,B1.(abinskisgn),,B,,,,

,,

(4-6)。1表4-6锥体束受损后的足部病理反射 B

nCiO i

iGiSiG iRlB

nCiO i

iGiSiG iRl(haddocksgn)

(msgn)

(ordonsgn)(chafersgn)(ondasgn),,(ossoimosgn) (i2.

Hofmannsgn)(i,,,,,fe3.(Massrelx),fe,(,),,,()80,3,,,,,,,4.,(),,,,,(fe5.

Grasprelx),(feL6.(),L,第五节

脑功能定位,,,,()()、(),()。,,,,,,,(4-24)。()1/3,,2z1.I

2z,6,,30%4,8%6,

Bet

3%,,,,,,,,81B(rodmman8),B,,,,BB42.BB4(roca),(5)。()a,,a,

,

(-graphi)。3.,();,()。4.(),1.,,,,,,(();(),,代表区分,,aiati i2.能相关区aiati i40(nomicaphasa),,,(caphasn)。,,,,()、()、()(),(),,1.,8240,c,,,c,

,,,

Wernike,,,22.,2,422,,,,3.,,4.,,,,(),,,(,);,,()l(t

imbicsysem)l(t,Papezs,,,,5-,,,,,,,,,,,,,()(4-35)。,,,,383,,,,,,(),“”图4-35右侧内囊的组成,,(4-36),()5,4cm,1.cm,305,(,,)、()()。()、()、(--)、()()。()84图4-36脑干失状切面(示间脑)(

ji,(

ji,()-

Deerne,),(,),,,(),,,(),4g,,,,0//1.-0//(1.06),290mmolL,8hL,2.“”,85“”,3.,,,,28℃4.,,,i(,Frohlchsyndrome,)。i,,5.-,,,,(),,,,()1.,,()()2.(

,,)3.

,,,,

,,,

,

()1.1le()(Wal),1le4-37),(,();,();();(

)();((86Dji)。(eerne):Dji,ll图4-37瓦伦贝格(Wa

nberg)综合征ll la e2()-(Mi la e2)(4-38):()、()()。()。():(),(),87(),(),(l),()。(ocked-inl):,,,lae图4-38米亚尔-居布勒(Milrd-Gubllae3,P

i()(),3,P

i

,(4-39)。(ar),88,,,,aii

ataii

atvit(scendngretculraciatngsysem)。o,,o,,

Bit图4-39韦伯综合征89第五章

神经系统疾病的常用诊疗技术第一节

脑脊液检查cllC(fuid,SF)cllCbii

B,bii

B,,,-(lood-branbarrer,BB)。,,,lt(ure)、lt,1.1()12(),23,3()2.12(),,12(),3456(),3456()()(),3.,,9028d,,,,,10ml46h,,4.1

,2

3

,34,,23,,,,,,,,,,2%12ml,,46cm(23cm),“”,,,,,46h,,,脑脊液常规检查1.()()。,802O,2O,2O),,4,,20mmHg0mmHg460mmHg,,1002O,,,(),(),,,,,,2.1(),1,,,,,2(),,2,,,,/(10g

L),/91i,

Froni36(),300×10/L

36060663.(5)×10/L06066×10/L10×10/L,,,P4.andy()P,,Pandy,,, /

55/ /

4/1. /

55/ /

4/75mgdl),50%70%,2.5mmolL(5mgdl),,//72.120L,(00//7,,,1//4112

////1153.1//4112

////1150.5g

L(025mgdl),0.50.5g

L(15mgdl)。,-1.,,,,,(2.,,(

)1224h,,,,92 γααβ3.():2% γααβ62%,1

4%8%,2

5%11%,

8%13%,

7%18%αβγαβγ

//14.,IgG0.10.4g

L//1 //01 6I Idl),gA0.010.06g

L(. //01 6I IS/ 77oi

l

lS,IgGS/ 77oi

l

lS,IgG/IgG)(/),≤0.,IgG0.

,24hIgGIgG(lgoconalgGband

OB),,,,,,,,,5.,,P6.(CR)P

(CT)C(T),,,,C,X,基本构成和成像原理XXCTX,

,,XXX,

,X,X,,,,CT

,X,X93μμXμ,T=[(~μ)μ]×a,μCT

X,,,,X,,,CT

C1.T

CT

,,CT,CTCC/aμ,aCT

(22(e

l2.

width)CT(22(e

l16,100Hu,CT

100/16=6.5,CT

6.5Hu,

windowlve)CT

,,CT

atf

t3.atf

t(),X(riacs),()、(),,p

ta4.(ari)p

ta×,,CTCT

CTCT

,CT

5.CT,,CTX,X()CT

1.,,,,,(OM),,,945 0CT5 00.1.cm,CT,,CT

,/II2.,/IIX,,60%70%60100ml,2mlkg,,(ohexol)(opro-),,()CT

X1.CT

,

Xvptcvptc,,CT(olumescan)。(ich)(olimaton)。X360°,,,X,,CT

,X1∶1,X,,,,,2.CT

1CC CiC89()T

T

(1CC CiC89,,CT,,CTA,,,CTA0.20.2CTAlCC,lCCCTA

WiisCT

,CT(Tvenogra-phy,TV)。,CTA,,2CC p

f

i()T

2CC p

f

i,,,CT

,,,95 CCit

lC3C()T

T

CCit

lC3C,,CT,,4Ctii3()T

CT(hreedona4Ctii33DCT

,360°,,,5(

t

e

at

toC()5(

t

e

at

toC,,,,,)

(MRI)磁共振成像基本技术及适用范围()T2rli121.(MRI)T2rli12T

),10%,,,,

MRI,,,(eaxaton)。

T

T

1TZl

ii

l

li()11TZl

ii

l

litudnareaxaton),,Z63%11,T

,T

112TYt Yl i2()2

2TYt Yl i2(ransversereaxaton),,

37%,,T

2.表5-1自旋回波序列各加权像的参数( ( TR

ms) TE

( (T1 50025T2 200075200025 sS1()(,E sS1961TTT2(,1TTT2(T

(1WI)、2

(2WI)(5-1)。()

GRE),,(i rai12(3.(i rai12(

Gadolninumdethylne-ticacd,Gd-DTPA),,XCT

,

MR

MRI,T

MR,T

Gd-DTPA,,

Gd-DTPAGd-DTPA-,-,, /121

T1Gd-DTPA, /121

T1Gd-DTPAGd-DTPAT

2

,T

WI,Gd-DTPA,,()1.,,,,

MR,,,,CT,,,,,2.,,磁共振特殊成像技术()(i,i1.

cresonanceang

MRA(i,iMKA,97(il,

(ilfowimagng)。

MRI

MR()、()。1()1(),90°180°,,,90°,,,180°,

MR,,,,,,,,,2()2,,90°,,,,“”,180°,,,

MR2.1(32()

TOF):1(32,,TOFTOFTOF(DTOF)(DTOF)。2 PTPfct()(C):2 PTPfct(haseefc)。,3,,3

PC

MRAPC

MRA2DD C13()(EMRA):, C13atiali

,3.MRAatiali

,,MRA90%95%,MRA,(rerlve-nousmaformatonAVM)MRAMRA,98prlli

at

PF,prlli

at

PFMRI,

MRA,

MRAMRAMRA,,MRA,(ercuta-neousintaumina

angoplsy,TA),MRA

MR,MRA()LAIRfF22221.(luid-atenuatedinversonrecovery,LAIRfF2222T

WICSF,CSF,,T

WI,FLAIRT

WITE,,T

WI,F22FF22.F22FF2FLAIK,,LAIRT

WI,,FLAIR,,T

WI,,,FLAIR,LAIRTSE

,FLAIRCSF,LAIR,FLAIRTSE

FLAIR,,,,1/3,CSF,

FLAIR,T

WI,,2/3,CSF()df

i i,1.(ifusonweghtedimagngdf

i i,,,df

iDai ifiiDWIdf

iDai ifii(pparentdfusoncoefcent,ADC)DWIADC,,ADC,,DWI,,,,(C P2.DWI(C PN-

NAA)、(MI)、(r)、(Cr),99()p

f

ii ,21.(erusp

f

ii ,2PWI,

MR,T

,,(r,,(rPWI

Rcbv)(CBF)(MTT)rCBF=rCBV/MTT2.()(i,t1.

cresonancespecroscopy(i,t,,1

32113(C(((Ly(2.1

32113(C(((Ly(1H1P1HMRS,

Cr)、(ho)、-

GABA)、

Glu)、

GLn)、(ac)N-

NAA),1H

MRSNAA,ChoCr(NAALac)()

MRIf

toi

foib ,1.MRI(uncinalMRf

toi

foib ,

MRIMRI,,,(xygenaton),

MRIfMRI(loodoxygenlveldBOLD)。22,,22,“”,“”,EPIT

WIT

WI

MR

BOLD

MRI2.,,,fMRI,100

SPECTC,C,,,,TMRI,79,,79,,,,,CTMRI,6%,6%,96%,()li-li———3/5-2/5,,

Wils()750850ml,,20%34,1500g,24h1100L2%3%,15%20%();25%24h115g,,,“”“”,,()1.10501012.1()12(r(),

CBF)2(r(CBF),3.,,脑显像与血流灌注断层显像()1.(-)()(-)。SPECT()

PET(),PET

SPECT2.CT,(),(),,,,CTMRI,,3.SPECT

,,1cm4.,,,()1.99mTc-ECD(),,,,SPECT

,102,,,,,04T1n22.99mTc-HMPAO

99mTc-ECD04T1n2,,94%,6h,,.min,10min3.,4.

c-ECD,555(525mCi),,

,

20mi

4hSPECT5.,

CO

常见神经疾病及其显像特点r(CBF)rrCBFCVDCVD,(),ls(12d)、TIA,ls,,HelmanTikofkySPECT

CVDSPECTrCBFCVD,,,,90d()1.sr,sr,

,(toke)。

,,,,24h,S,,2.SPECT

,,CTS,,1cm,,PECT,

CTSPECT

,,

CTMRISPECT103SPECT,CTMRI,,CT

MRI,8,,,

31.

%

854%,,,()1.TIA,-riesifctRriesifctR,24h,24h(eversblichemicncdeii,IND)。1TIA,,1/3,/31,1/3TIA2.TIA(),,CT

MRI,()rCBF,,/,18.%,CBFrCBF,,,((

a Daa

Acetazolmide.ACZ),

((

a DaarCBF20%,,rCBF,DimoxrCBF,imox,()1.,50%2.CT

MRI,1224h,rCBF()1.,55,,0.%104S2.,,,SEEG,,SPECTrCBFEEG,,PECTPET,6%,SPECT

,,,rCBF,()1.1(Pcz

i()

Al1(Pcz

i)、2 ( i()

2 ( i3()3,,,2.1)(z

iC(

Alhemer

AD):1)(z

iC50,,T

MRISPECT

AD,,(),,,2((

tti,3

Pc2((

tti,3

Pc

muli-infarcaMID)。,,,

MRI()ik,4560,,SPECT,AD

MID4()4PP(arkingscmdsease,D):PP,5060,,,(i’

i

HuntngtonsD(i’

i105,2050,15rCBF

PD,5(),520%,2,,CTMKI,,,rCBF,6(),6,2040,,rCBFrCHF,rCBF7()CTMRI,SPECT7,rCBF,,rCBF,8rr()8rr,,CBF,CBF9()9rCBF,,rCBFCBF,rCBF,rCBF,

1.,,,2.1(),1106,

PET

PET,

PET

PET

11C3N5O8F,11C3N5OCNO,l8F

H,(1C20min3N10min,5O2min8F110min),7.

11C8F

2448h2448h2()2第五节

正电子发射断层扫描成像p

irsi P(osp

irsi P,

PET

PET11 111,,y,PETl l11Ccc1.Ccc,,(MR-gl

rCMRgl);/(/)2.C C3.,C C,(BFrCBF)(BVrCBV)。15O,,,C 22(4.15OC 22((MRO

rCMRO

)

OEFrOEF)。5.18F(),6.()、(),

PET

1D, (((AT),

DAT

5-

D, ((HTT)

NET)P,ET

P107i,,,8F-FDG

l8F-(8i,,,8F-FDG

l8F-(8F-FDG)

18F-(8F-FDOPA)

15-(H52O)

15-(5o2)

11-(1C-MET)

11-(1C-NMSP) D2

11-(1C-Cocane) ,

PET

,5-2表5-2常用PET脑造影药 l11C15

-

(15O)C1111,18F-FDGPET

,90%,1F4F4,6-F4F4,DG-6-PO

6-,6-,,

PET

18F-FDGy大脑正常影像特征,4,18F-FDG,,1.1(),1108),),8F-FDGPET(EG)、TMRI8F-FDGPETEC,,,,CTMRI,,,l8F-FDG11C-METPET,,,2(),2,X

CT(l,l8F-FDG,20,,90%PET,2.,γ,1,,E,60%90%E,,PET,11C-METPET,PETEEG

MRI,(CoG)PET,

EEG

,EcoG,PET

,z

i(3.,z

i(Alhemer

AD)18F-FDGPET

ADAD,CT

MRI,18F-FDGPET

,(5-1)。109,(A)PET

PD,(A)PET

PD8FD-dopa,D,DA8F-FDOPAP

F-FPCIT

,D,Pz

iBA.晚期AD见双侧顶叶,联叶,额叶葡萄糖代谢明显减低;.早期AD仅见双侧顶叶代谢减低Bz

iPikli Pc,z

iPikli Pc,PET

Alhemer,AD,ADPET

c

Wison

Huntngton

(DD),,rCMRgl

,,PETP,,P,,,,,,,,,ADADAD,,4.(D),1lPc,Pc,ET

PDPD,PDCMRgl

l8l

PD,110F-FDGPET

F-FDGPET

,5.1r 2rrc22/12r1r 2rrc22/12r,,,,,,,,,PET(CBF)、(CMRO

)(CMRgl),rCBFrCMRO

,rCBFrCMRO

,FDG,rCBF12ml(00g·min),CMRO

/165μmol(00g·min),/12 P( (25 (()2 P( (25 (,,,

ACZ)PETCBF

OEF

TT),()H1O

AVM),6.PET

P,,PCT

MRI,ET

,

PET,,CTMRI,PET

,18PET

,

MRI,CT

MRI,,,,,18F-FDGPET,,PET,,,,,PETAIDS,,111,CT

MRI第六节

脑血管造影检查,,,dlr

to,ie(igtadlr

to,ie

,,,,X16031.

X500mA,50kV,3/X1603,0.,.,,,(5-2)。 152., 156.F,04F,HSH,‘’,3.,,,,,,Conrav,,图5-2GE双C形臂数字减影血管造彩机器11212()12()3(),312()12()3(),3,,X,1.,1(),,1,,,,,25055()1.2.cm1%250554ml,,0.cm,,45°60°,,,,,,,,,20,,,,,,,,,,,,,,,,,1∶100020ml,,1015min,1h15min1,30min1,1,6h,,12h2.,,,,113(),,6s,,,,2h3.,,,,,4.,,,,,,1cm,20min,6h1.,,2.,正常脑血管造影表现图5-3正常脑血管造影图像B; ;A.主动脉弓上血管造影;.颈总动脉造影

C.颈内动脉造影侧位像

B; ;1.1(),,1,,,,,,,,2311429()0%,2

23,,292cm3()1

,,,3,4(),2,4,,,,,5(),5,,,,,,,,,,,6(),,,6,,,,,,,,,,X,,,,“”,,,2.1(),,1

,,,U,,,U,,,,,,,

,,34cm,5cm,,,,,,(5-4)。115图5-4正常椎动脉造影图像BA.椎动脉造影侧位像;.椎动脉造影正位像B2(),2,,,,,3.-,1(),,1,,23(),,,23,,(),,,4.1()1a():,612,aTrolrd,,iL(Sylvan):,iL():,(abbe),2(),,2,,,,,116,,,,,,,,3l,,l,1cm,,

,,,,,“”,5,11.cm,5lGaen,,,l,,,3(),3,,,,,510,34,,5,6.,234()4,,,,,,,,,,,,,S,,,异常脑血管造影表现1.1 1D()931,ot

1 1D,,,,,2(,S

iel1()

AVM):tenl2(,S

iel1117AVM,,,,,,3(),3,,,4()():4,,,,5(),5,,2.,,1(),,1,,,,,,2(),2

,,,,3(),,,3,,,,,,4(),4,,,,,5(),,5,,,,,6()6,118,,,,,,,3.,,CTMRI,1(),1,,,,,,,,,,,,,2(),2,,,,,,,,,,,,,,,,3(),,3,13cm,,,,,,,4()4,,,,,,,3,,119第七节

超声检查,ce

l t,iece

l t,ieagng,CDFI)(ranscranilDopplrTCD)1l1201l12090CraVEN(990)

Saonen(991)CDFI,()。()(liC

TCD)2080(Wils(liCTCDT,T,T,CD颅脑多普勒超声eTCD1943eCh.Dopplr,,(),(),(),(),doθdF=2F

VcosdoθdoθC oθdoF

()doF

v120

PI=(VP

PI=(VP)-(DV)

RI=(VP)-(DV)Cθcos

θcccc,os0°1,os90°0,TCD,,()T1.CDT1d()(epth):1d,2dr

tolT()(iec2dr

tolT,,,,,,3,(vlillip ,el3,(vlillip ,eliitili

E (veoctyVM)、(ndofdasolcveocty,DV)。VPEDVVMVPEDV,

Vm=

VP-EDV/3)+EDVVMVPEDV,4p

siiPritR()(4p

siiPritRE(

VM)(E(

VP)(P1 B71 9 1P6 58,IP1 B71 9 1P6 58(985)A

MCAPI0.1±0.00.4±0.4B.A,PI,PIPIPI,,,IPI0.51.0RI0.50.5PIRI,P,,,P,,IRIT2.CDT121,,

TCD TT3.CD,CD TT1 ceitClit-()1 ceitClit- iEli tIy,CA)、 iEli tI c -i

iCla2 pi to s c -i

iCla2 pi to s l togton4)、(enuporin3)、(upracinodporinC2),o ,l

c

t(phthao ,l

c

t (l

t3 p

tirta (l

t3 p

tirta i rt(nterorcerebrala

ery,ACA)、(oserorcerebrala

ery,C ( PPCA)、(AJ

C ( P v

t l

t ,p

ti4()- v

t l

t ,p

ti4 b

ia tPlat Binferorcerebelrarery b

ia tPlat B d ,l5()(eepmiddlecerebra d ,l5BS(VR)、(BS()1.TCD,1PIBB()1PIBB

MCA

ACACACA,A(PCA)、DMCVVR2(),2OA3 BP,()VAAICA3 BP,VA

TCDVAVA,VA,VA4()CCAICAECA4,()ICA2.1(),1

S1,,,,,S2,,,1221,D,10.0±0.2(,1996)。2()2,,,1,,1,,,0.2s,,

PIRI,,P,,,P,IRI,,,,,TCD,,,,,,,,,,,,,,,,,3.i,,i,,,“”(MuscMurmurs)。,,123T4.CDTCD,T,1P()1P,OA,VAICABA2,()

TCD2,3,(),3,,,ACA,,,

ACA,

MCA,4,1()-4,170%,30%,

20%30%-MCAACAPCA≧

BAVA≧

PICA

MCA≧ICA

51()ICA51ACA

MCA

MCA,ICA1

ACA,

MCA1ACA,ICA

16CP,()CACCA6CP,CCA,MCA,CA

ACA,CCA,7(),PCA7,

PCA,

PCA()1.T,,T,CD1()TCD,,1,,,,,,124,,2(),2,,,,,,,T(9s(B

ssST(9s(B

ssS,

Vm)0/,30%()。

MCAA

VAICA),50%69%,70%,

Vm

120/,Vm/,/,,,,P,l2T29 ,2P5s ,sP,l2T29 ,2P5s ,sP , sP7P,(002)TCD,50%

DSA136TIA,CD40(9),6(

),TCD93.%,91.%,PV77.%

NPV97.%

MCA,

MCA

50%MCA

MFV/,100%,96.%,PV84%

MCA

MFV/,100%,97.%,PV88.%

NPV94.%MCA

MFV≧/,68.%,100%,PV100%

NPV94.%ICA,,2∶1,,,,,,a 2PP,a 2PP

MCA,

TCD.MCA

MCA45,80MCA,

MCA,b.ACACAACACA,(0%125(30%)。c.MCA(M2)

MCA

ACA/MCA),(,i 2a2sc11 P1

MCA

,

MCA

i 2a2sc11 P1MCAScotBurgn(000)TCD

MCA,MCA,.MCA

MCA();b.MCA,(0.s),Vm/,,,Vm()30%,.(IM),(

MCA

TCDACA,ACA1

ACoA,出现一侧ACA

,ACA

MCACA,ACA

-ACA,,ACA

MCA30%,,ACA,ACA,ACATCD11ICA

ACAMCA11ICA

ICAACA/MCAACA

MCA(),

MCA

ACAPCA

MCA

ACA

MCA

ACA()。3(),370%

,,70%TCDI1,I1,

MCA

ACACA

,PCAACAI1I 1,

MCAI1I 1

MCA

ACACA

,PCA内部出现()。数的变化PI患侧动脉的PI,abc3.ACA();.ACAabc3.

MCAACA,CCA,

MCAACA,

126a 1 bc.

PCA(

MCA

ACAa 1 bc

PCA

PI

MCA

ACA,

PCA.CCA,PCA,abcP(,abcP(,,.,,.,.,I2.-

VBI)VBI

TCD1()1,VA,VATCD,VABA,,VA,VBI,(),TCDVBI,

BA,2()2B

VA

BA,,,BVAA,VAVA,VABVABA,VAAB3,,3()VBI,VAVA,VAVA

BA,,VA,VA(),

VA()。a,VAa,.(50%),TCD,VA,,,b.50%,VATCD“”,(),()127c.,VA

,,VAVA,,()。BAVAVA,BA,VBI

BA,,,3.AVM,,,1()

AVM,134,,,342

,,,2∶1(22.∶1)。2P/P()AVM

,2P/P,,I(I=VP-VdVm)。PI6,60.51.0AVM

PI6,63()TCD34,(),,“”4,()AVM,,,,,

AVM“”5,1,()AVM,5,1,,ACoAAVM

ACA

AVM,,,,,6(),,6AVM,,TCD,CCA

MCA,AVMCCA20%30%,AVM

CCA,AVM7)(

AVM-7),,128,AVM,,,,TCD()、(),AVM

siS4.(,AH)siSSAHTCD1,()TCDSAH,1,

TCD,,,,,12,,,2

l1P()

Aasid1984986先后发表TCD2

l1P

MCA

MCAICA,,ACACA(,),

MCA,,ICA,

MCAICA,,,

MCA,,3ST()AHCD3ST,SAH412dSAH1993199546,,7,3/,,0%

SAH48d7,3/,,

12,4,

1d

(

PIMCAICA),20%30%

MCA∶ICA3∶1,,C5.CICP,(CP),,,ICP,,ICP,129li

l11982AasidTCDli

l1CCPKlngehSer(991)TCD,IP1 I,P113,IP1 I,P1,CPRI1992Chan

PICCP,

PIRICPPCCP70mmHg,I(993)PIICP相关关系,ICP

H(997),CP

CBF(),I0C0CPI3.

,BF20%,

PI4.

0C0C I1IT12()TCD I1IT12ICP,,,ICP,ICP,MCDICP“”S

S

,,,2,TD8F()TCDICP,2,TD8F,

TCD形态可分为45ICP平均动脉血,CD缩期出现的脉ICP平均动脉血压,,,(FI=1-R/F)0.R,

,ll1l6.1991AasidNewel,ll1l

1994Joanna995Va,13TCDTCD1996TCD,1998,160,1( sB919c9.()1( sB919c9.DMCV58(.±2.)m/(VR):BVR419(

2± s S s7c2.)m/(S): s S s7c2,B()TCD,2,B,DMCVBVR,DMCVBVR

DMCVVRTCD,,T7.CDTCD,T,,,1301 15,

MCA1 15(2h)Spenccr(997)500CEATCD,min12微栓子的16%,5min以上发现19%200.43/min,4230.29/min,1()TCD,TCD1,,,,300ms3db,,,,“”、“”“”。2),(

TCD

2),,,,t

2Csst

2CssDrose(002)TCD33,58d,/s,325/h,T

MRI

,/

/,≧/s,颈动脉超声检查IE()(IE)、CCACACAVASA05,68001.CCAIMT05,68001.1.cm-

,CCA,0.0.cm,,1.cm1.cm,3.,CCA,CCA1.000 542.ICA4.6.000 541.1.cmICAIMT,ICA0.56 00.5cmIMT1.6 03.ECACCA,131E E,ICA,CA,CAE E334.,330.0.5cm43%,,,(),,,,,,ICA,ICA5.,-,,,,,(),,,,123f1Irzo51.,123f1Irzo5IMTBond(989)IMT1.,IMT1.,Toshiumi(997),MT1.

Patii

,1.IMT1.,IMT,,1(),,12()IMT

,-,25,IMT1.,552.51.,,,,IMT

t1t1,Sizer(995),TCD,,,,,1321()1,,,,,,“”,2()2,,,,,,,3.,,1I()CCACAECACCAICA1I50%,70%,50%,,(50%69%),,,,5(70%99%),1.,,5E,,E,ECA,CCA,CCA,ICACA

,,,,2(),,2,,II,IICCA,CAECA,ECAICA,CCACAECAa0,a0.,1.cm,133bcde.,,bcde.,.,.,(),4.,,1(),-,12(),2,,3(),3“”,5.1(),161.cm62()-,23(),,3,6.,“”,,-,,,,7.,,,,,,,,,,,,8.,1341()1()。,,2()2,,,,,CCA,3(),3,第八节

神经心理学检查,,,,,,,,,,76,,76,0.5%4.9%,,,,,,1.,,,2.,3.,4.,135,5.,,,,6.,rlalt,(eirlalt,,

,vl(aidty),vl,,,,,,,,,,,,,,,,,,,,,1.,2.,,,,,,,136ltlilllltlilllintelgencescae,WAIS)、(ermemoryscae,WMS),,,,,,,,,,,,,,()100%,,,,,,,,,AD(MID),Hachinski,,,,,,,常用量表及其检查方法s (,s (,,,(MMSE)、Mati

DRS)、(CADAS)(ERAD)(C1.1()(MMSE):MMSE1,30,137899 0510min0.00.9,0.5899 080%90%,70%80%,,,,,,,,MMSE,,2IeI()--(MCT):MCT19682IeI,,,,IMCT

,,,,36,1994,3EsE,,3EsE()(SD):SD

Hersch1979

Mati

1 2 29674,1 2 296748,,823,250,154920817ESD0.,0.90.8,ESDESD,85.%,,4(1()

HDS):HDS1974,4(1,

MMSE,3,3,30,,,,HDS,,,,,

MMSE

HDS5()(WAIS)(WMS):(WAIS)5198211,,,1381,1(WMS).,7,987673,,,WMS6CCC()(

AMCOG),(6CCCRoth1986,,8,(AMCOG)CAMCOG

MMSE,CAMCOG,,,AD,CAMCOG

MMSE

,,7S()7S,997min42s,“”。,9996%,0.1,0.2

,,8C()(ASI):,8C9,20,1520minCASI100,

MMSE

HDS,,8988,

Kappa0.6,89880.7,0.9CASI,

MMSEHDSCASI,,2.1 (()

ADL):ADL1 (ADL,,,,,ADL

ADL139( I

ADL)(ADL)ADL( I,,ADLIADL012012(

)、(

)(

)2 FF()(AQ):AQ2 FF,,FAQ,,,,,,,,ADL,02,303.1 CiC()(DR):DR1982

1 CiC,,,CDR-,,,,05123,,05123,,,0.

,CDR,CDR,2(,,GG()

GDS):2(,,GG,,1,7GDSMMSE,GDS4

MMSE1623DS,

MMSE,DS3)si(

Mati

(MatsDRS):3)si537,1530min,144,,,15min,5,,,“”,,-

MCI4.1(()

NPI):,,1(,NPI10,,1402BB,2BB,AD4(X)144(4×3×12)。,4()(AHAVE-AD):AHAVE-ADAD,,,,20min1)(55.1)(5,,

ADVD,(

Hachinski

HIS):HIS

Hachinski1975,AD,≧7,6,≦4ADRosen,70%,2II5512()(2II55121986,AD,AD,,IDCF-DAT10,

,

,0

AD,AD14,100%AD94%AD,,AD,141第六章

脑电图检查第一节

脑电图E(EG)E,,,,(,)、,1875,Caton1924HansBerger,19361947“”,1(,

,1(

,958,

TEEOVR)()、()8128(),()102010%20%,,142()(),第二节

脑电图的分析()(

6-1),,

ms( 图6-1脑电波周期波()C,/(/S)(6-2)。C图6-2()()(6-3)。图6-32725μV()27575μV5100μV100μV()143(),(6-4)。图6-4()β,αβ()(),Alpha,,(),(),,()(6-5)图6-5脑电图各成分示意图1442.6.

2.6.

α1.

α/

1813cs,0100μVα,/

1()。β/

5β1430cs,20μVβ,,50μV/

5βα,

β,βθ3.θ/47cs,10200μV,θ/,,θ10%δ4.

δ5 /0.3cs,10200μV5 /γ5.

γ/3345cs,25μV,,/μ/,711cs,50μV,μ,/,λ7.

λ/35cs,1040μVλ/κ8.

κ/610cs,/9.1

/80200ms,100μV,2cs1

/,10.80ms,2060ms100150μV,/,,1/3614cs/,,11.12./,23cs,/14513.,αβ14.,300μV,δ15.

δ/(,κδ14cs,

/(,κ16.-1/κ-1/(216cs)

,17.,30%,()。18.,,()()1 3(

3)、(

1 3)、(10)、(,,,)、()、,,,,()(),25μV27575μV275100μV146100μV(),,(,,,)。儿童正常脑电图/3/δ3/4//3/δ3/4/α2,,(5cs),,35,

,5cs,()。611,7cs,θ()。/1,58cs,/,δ //35,

,,θ,810csδ //,46csθ,δ3(6-6)。3图6-6正常儿,男,

岁,清醒。正常范围脑电图3 8 /θ68,,12csα(),α 8 /θβ,6βα//δ910,

,αα//δ

78cs,θ,

1210α,150μV1117,,,θδ儿童异常脑电图1(),1147()

()

2()23()344/ //()

6cs,64cs,44/ //9 / /,

8cs,1049 / /5()5成人正常脑电图α()

α5/αα,,,1.cs,5/θβ,()(79%,6-7)。θβββ,2030μV,50μVββ(4%)。()βα,20μV,,θβα(7%)。4图6-7女,2岁,觉醒。正常α型脑电图4()α,α,β(10%)。成人异常脑电图()1αα()

,α,,

1αα148/■1cs/5/

22.c5/5/■0.c5/α150μV,50%2 β()β,50μ2 β3θ4()(1015%),3θ4(),--5()α5()1θ(),θ1θ23(),23(),-,-45(),1045()δ1δ()1δ()

2()23(),34()(10μV)。4,,,,,,,()α,θ,,,(),,δ()3/δ(cs),,κ-3/1/(216c1/()δ,300600μV,/47csθ,/149()(),α,βα,,

,αα,,,(()

HV)(2 2CO

,CO

,pH2 2,,,,,,()30%,80%,2/3,,()--,,-,,,(),,,,--,,,-,90%-,-()22,O

-150第三节

脑电图的临床应用(),,δθ(6-8)。//;/;B; F/A.发作前:为11cs广泛性α波;.先兆期:为5cs之θ节律

C.完全强直//;/;B; F/完全强直期:棘节律频率较前减慢

E.阵挛期:阵发性节律性慢波和多棘波;.恢复期:开始为平坦坡,后为中等波幅慢波并14cs之睡眠纺锤波。2图6-8某女,8岁,癫痫大发作(发作期)脑电图2()/ /3cs-,2c/ /-(),,

,,()//6cs14cs,,//151()/ /46cs3csS,/ /(),(,)。5090%,,,,θδθ,,,,,,,,,,,,,(6-9)。1图6-9某男,6岁,病毒性脑膜炎继发癫痫1/觉醒以5~6cs节律为基本节律,伴有阵发性高波幅(最高350μV)// /δ2~3cs及4~6cs

和θ节律、棘波和尖波发放,偶见棘-慢波/ /δα,,,α,

,,152,,,θααθθδ,

ααθδθ,

(δ),,ααα,,,αα

,α,,,20%60%,30%,,α()

αα,α,α(),(),2/6cs/()20%25%()64%-1531.α,θδα,2.αα,θ3.α,θ(脑功能轻度障碍)

24(2424

AEEG)。(,24,,,1

2248,6,41

224

,,动态脑电图的适应证,,,

,,异常动态脑电图表现1()12()2154345(),345(),-()6()67()7动态脑电图的优势与不足()1()12(()X

CT)、(MRI2(345()345()()6(),,6()1234()1234(),()()动态脑电图检查的临床意义1.,,2.,1%5%3.,,4.,25,20,11,5,1555.5,,5,0%10,,,,10,,,906.,12,,,,,,1030,,,34,7.,,,,2,34,,--C,,C,,,T

MRI,,,,,,,CTMRI,第五节

视频脑电图1936,,,,156a215,a215Video-EEG)20,,,Kolr66-,3,7,3,,,,,,,,,(,,,视频脑电图分析,,()()-,,-,,,,,,,,,视频脑电图对癫痫诊断和(),,3030%,,,50%,95%

OldAni23,52.%87%(6-10)。157图6-10视频脑电图6某女,

岁,临床诊断:原发性癫痫6注:视频脑电图检查见临床发作伴尖波发放()5%20%,“”。,(),,,,,,,,,,1.,,,Hamer76

296,,24%,20%,17%,20%,5119,37%45106,218,32,3,3,52.,,,,-3.,1584.,(),,,()(),,,,,10,,159第七章

神经系统疾病症状学,,第一节

意识障碍c i(onsc),c i

,,,,

(),(7-1)。■嗜睡■嗜睡()

ss昏睡状态(opor)s意识水平下降的意识障碍■

■浅昏迷伴意识内容改变的意识障碍

意识模糊(伴意识内容改变的意识障碍

意识模糊(onfuson){■c)■ ■深昏迷意识障碍■c idlru t tctdlru t tctd去皮层综合征(ecoriaed)aki

i i特殊类型的意识障碍■无动性缄默症aki

i i■

l■(醒状昏迷comavigi)l图7-1意识障碍分类160,,1.,,,,,,,2.,,,3.,,12()()

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论